News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
Roche (RHHBY) Purchases Shares In Tender Offer For InterMune, Inc. (ITMN) 9/29/2014
Alimera Sciences (ALIM) Provides Details On FDA Approval Of ILUVIEN® As The First Long-Term Treatment For Diabetic Macular Edema 9/29/2014
Lpath, Inc. (LPTN) Announces Closing of $12.5 Million Registered Direct Offering 9/29/2014
Agrisoma Biosciences Inc. Announces Closing Of Series A Round 9/29/2014
RXi Pharmaceuticals (RXII) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/29/2014
AVANIR Pharmaceuticals (AVNR) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/29/2014
NeoStem, Inc. Secures Debt Facility 9/29/2014
GW Pharmaceuticals Research And Development Day Details 9/29/2014
Asterias Biotherapeutics Announces Distribution Date Of Biotime Warrants And Conversion Date Of Series B Common Stock Into Series A Common Stock 9/29/2014
Alimera Sciences (ALIM) Provides Details On FDA Approval Of Iluvien® As The First Long-Term Treatment For Diabetic Macular Edema 9/29/2014
BioTie Therapies Corp.'s Financial Information In 2015 9/29/2014
Tesaro, Inc. (TSRO) Announces Closing Of $201.25 Million Public Offering Of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise Of The Underwriters' Option To Purchase Additional Notes 9/29/2014
"Cascade” Of Biotech M&A Will Transform Specialty Pharma: Cowen 9/29/2014
Analysts Say Valeant Pharmaceuticals International (VRX)/Allergan Inc. (AGN) Deal Could Lead To Buying Spree 9/29/2014
Cellceutix (CTIX) Provides Update To Shareholders 9/26/2014
Analyst: Novartis AG (NVS), Celgene (CELG) Might Go Toe-to-Toe Over Psoriasis Drugs 9/26/2014
Gilead Sciences, Inc. (GILD)'s Harvoni Will Fast Track: Analyst 9/26/2014
AVEO Oncology (AVEO) Terminates Cambridge Lease Agreement To Save $110 Million 9/26/2014
Amarantus BioSciences, Inc. Shareholders Approve All Matters Voted Upon At Annual Shareholders Meeting 9/26/2014
Galena Biopharma  (GALE) Announces Release Of Special Committee Report And Hosting Of A Conference Call To Provide A Corporate Update 9/26/2014
Karyopharm Therapeutics (KPTI) To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014 9/26/2014
HEALTHSOUTH Announces Date Of 2014 Third Quarter Earnings Conference Call 9/26/2014
Pentwater Capital Management Issues Letter To Board Of Directors Of Allergan Inc. (AGN) 9/26/2014
China Cord Blood Corporation To Hold Annual General Meeting In Hong Kong On December 11, 2014 9/26/2014
Allergan Inc. (AGN) Issues Statement Regarding Recent Valeant Pharmaceuticals International (VRX) Correspondence 9/25/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/25/2014
Regeneus (RGS.AX) (ASX:RGS) Receives R&D Tax Incentive Refund Of $3.7 Million 9/25/2014
Antisense Therapeutics Limited (ANP.AX) Release: Placement And Share Purchase Plan 9/25/2014
Hurel® Corporation Completes Investment from Johnston Associates, Inc. 9/24/2014
What Happened At BioPharm America 2014? 9/24/2014
ProQR Therapeutics B.V. (PRQR) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/24/2014
Lipocine Inc. (LPCN) To Host Conference Call And Webcast To Discuss Top-Line Results From The Phase 3 Study Of LPCN 1021 9/24/2014
Hyperion Therapeutics (HPTX) To Host Analyst Day September 30, 2014 9/24/2014
Tesaro, Inc. (TSRO) Announces Pricing Of $175 Million Of 3.00% Convertible Senior Notes Due 2021 9/24/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 9/24/2014
TNI BioTech Announces Its Stock Is Now DTC DWAC/FAST Eligible 9/24/2014
AVANIR Pharmaceuticals (AVNR) Announces Pricing Of Public Offering Of Common Stock 9/24/2014
Expiration of the U.S. Tender Offer For CFR Pharmaceuticals 9/24/2014
Valeant Pharmaceuticals International (VRX) Provides Update On Third Quarter Results And Sends Letter To Allergan Inc. (AGN) CEO And Lead Independent Director 9/24/2014
Clinigen Release: Underlying EBITDA Up 19.8% And EPS Up 22% 9/24/2014
The Medicines Company (MDCO) To Webcast Infectious Disease Care Investor & Analyst Day On September 24 9/24/2014
TAP Biosystems Release: New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors 9/24/2014
Hurel Corporation Completes Investment From Johnston Associates, Inc. 9/24/2014
Baxter International, Inc. (BAX)'s Deal With Merrimack Pharmaceuticals Inc. (MACK) All Upside: Analyst 9/24/2014
Analysts Say ZS Pharma (ZSPH) Continues To Gain On Drug Approval 9/24/2014
Analysts Say Biogen Idec, Inc. (Massachusetts) (BIIB) Must Push Into Gene Therapy To Stay Competitive 9/23/2014
Tesaro, Inc. (TSRO) Announces Offering Of $165 Million Of Convertible Senior Notes Due 2021 9/23/2014
Supernus Pharmaceuticals (SUPN) Provides Business Update 9/23/2014
AVANIR Pharmaceuticals (AVNR) Announces Proposed Public Offering Of Common Stock 9/23/2014
Inivata Raises £4m To Realise The Potential Of Ctdna Analysis To Improve Cancer Treatment Through Simple Blood Tests 9/23/2014
Xenetic Biosciences To Hold Business Update Conference Call September 23 At 6:00 A.M. Eastern Time 9/23/2014
NetScientific plc Release: Half-Yearly Report 9/23/2014
Pfizer (PFE) Invites Public To View And Listen To Webcast Of October 28 Conference Call With Analysts 9/23/2014
Cellectis (ALCLS): Individual Shareholder Meeting 9/23/2014
TapImmune Inc. (TPIV) CEO Provides Update On Corporate Activity And Progression Of Clinical Programs 9/23/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Named Global Biotechnology Industry Leader On Dow Jones Sustainability World Index 9/23/2014
Analysts: New Inversion Rules Won't Scuttle Mylan Inc. (MYL), Medtronic, Inc. (MDT) Deals 9/23/2014
Wall Street Overreacting To Inversion Proposals, Says ISI Group 9/23/2014
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Full Year Fiscal 2014 Financial Results On Thursday, September 25th, At 4:30 P.M. EST 9/22/2014
Xstelos Announces Intention To Vote Against Affymax, Inc. (AFFY)'s Plan Of Liquidation At September 23, 2014 Special Meeting of Shareholders 9/22/2014
Skyepharma PLC (SKYEF) Announces Notice Of Early Repayment Of Euro CRC Facility 9/22/2014
Nordic Nanovector: Registered Share Capital Increase 9/22/2014
Xenetic Biosciences To Hold Business Update Conference Call September 23 At 6:00 A.M. Eastern Time 9/22/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event 9/22/2014
Aratana Therapeutics (PETX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/19/2014
Lpath, Inc. (LPTN) Announces $12.5 Million Registered Direct Offering 9/19/2014
DiaGenic ASA – Notice Of Extraordinary General Meeting 9/19/2014
ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million 9/19/2014
PharMerica Announces New Senior Secured Credit Agreement 9/19/2014
Can-Fite BioPharma (CFBI) Files June 30, 2014 Interim Financial Statements 9/18/2014
Oncothyreon Inc. (ONTY) Announces Proposed Public Offerings 9/18/2014
Oncothyreon Inc. (ONTY) Prices $40 Million Concurrent Public Offerings Of Common Stock And Preferred Stock 9/18/2014
Nuvilex (NVLX) Updates Shareholders On Recent Activities And Discusses Future Plans For Development Of Treatments For Cancer And Diabetes 9/18/2014
Agilent Technologies Inc. (A) Board Of Directors Approves Separation Of Keysight, Declares Special Dividend Distribution Of Keysight Stock 9/18/2014
Tokai Pharmaceuticals Announces Pricing Of Initial Public Offering 9/17/2014
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 9/17/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share 9/17/2014
Synereca Pharmaceuticals Announces Financing Led By Accele Venture Partners 9/17/2014
Novadaq Corp. To Host Analyst & Investor Day On November 17, 2014 9/17/2014
Aratana Therapeutics (PETX) Announces Proposed Public Offering 9/17/2014
Chindex International, Inc. (CHDX) Stockholders Approve Merger 9/17/2014
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio 9/17/2014
Auxilium Pharmaceuticals (AUXL) Responds To Unsolicited Proposal From Endo International plc (ENDP) 9/17/2014
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell On September 17, 2014 9/17/2014
Aastrom Biosciences, Inc. (ASTM) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/17/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development 9/17/2014
Syneron Inc. Announces Details For Upcoming Investor Meeting 9/16/2014
Valeant Pharmaceuticals International (VRX) Announces Redemption Of All Of The Outstanding $500.0 Million Aggregate Principal Amount Of Its 6.75% Senior Notes Due 2017 9/16/2014
Nordic Nanovector: Final Result Of The Subsequent Offering 9/16/2014
Pivotal Therapeutics Inc. Grants Incentive Stock Options 9/16/2014
CorMedix (CRMD) Amends And Restates Outstanding Securities To Remove Provisions Causing Derivative Liability Classification 9/16/2014
Opexa Therapeutics (OPXA) Announces Termination of Public Offering of Common Stock 9/16/2014
Allergan Inc. (AGN) To Hold Special Meeting Of Stockholders On Originally Scheduled Date Of December 18 Without Restriction 9/16/2014
Opexa Therapeutics (OPXA) Announces Proposed Public Offering Of Common Stock 9/16/2014
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell 9/16/2014
Ampio Pharmaceuticals, Inc. (AMPE) Announces Webcast For Annual Shareholder Meeting 9/15/2014
Inovio Pharmaceuticals (INO) Begins Trading On NASDAQ Global Select Market Exchange 9/15/2014
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 9/15/2014
Antibe Therapeutics Inc. Commences Trading On The U.S. OTCQX Marketplace 9/15/2014
Akebia Therapeutics, Inc. (AKBA) To Ring The NASDAQ Stock Market Opening Bell 9/12/2014
Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend 9/12/2014
Novavax, Inc. (NVAX) To Host 2nd Annual Analyst And Investor Meeting 9/12/2014
NPS Pharmaceuticals, Inc. (NPSP) Stock Trading Halted Today; FDA Advisory Committee To Review Natpara® Biologics License Application 9/12/2014
Veeva Systems, Inc. To Host Analyst Day On Sept. 17, 2014 9/12/2014
Kolltan Pharmaceuticals Inc. Files Registration Statement for Proposed Initial Public Offering 9/12/2014
Aastrom Biosciences, Inc. (ASTM) Announces Pricing Of Public Offering Of Common Stock 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Orexigen Therapeutics, Inc. (OREX) To Host Conference Call And Webcast At 8:30 AM Eastern Time September 11, 2014 9/11/2014
Portage Announces Proposed Private Placement 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Roche (RHHBY) Again Ranked Most Sustainable Healthcare Company In The Dow Jones Sustainability Indices 9/11/2014
Fibrocell Science, Inc. Hosting R&D Day On September 24, 2014 9/11/2014
Intuitive Surgical, Inc. (ISRG) Reports New Employee Option Grants For September 2014 9/10/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 9/10/2014
BrainStorm Cell Therapeutics Inc. Provides Update On NASDAQ Uplisting Process 9/10/2014
TNI BioTech Announces Results Of Annual Shareholders Meeting 9/9/2014
Polydex Pharmaceuticals (POLXF) Reports Equipment Upgrades And Continued Profitability 9/9/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 9/9/2014
Relmada Therapeutics Provides Its First Corporate Update As A Public Company 9/9/2014
Regeneus (ASX:RGS) Share Purchase Plan Closes Oversubscribed 9/9/2014
MabVax Therapeutics, Inc. Receives Stockholder Approval For Name Change And Reverse Stock Split Resulting From Merger With Telik, Inc. (TELK) 9/9/2014
Clovis Oncology (CLVS) Announces Exercise In Full By Initial Purchasers Of Their Option To Purchase An Additional $37.5 Million Aggregate Principal Amount Of The Company’s 2.50% Convertible Senior Notes Due 2021 9/9/2014
ContraFect Corporation (CFRXU) Announces Separation Of Units Sold In IPO 9/9/2014
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustments For Convertible Notes 9/8/2014
EndoStim Files Registration Statement For Proposed Initial Public Offering Of Common Stock 9/8/2014
Intrexon Corporation Announces Filing Of Form S-3 Shelf Registration Statement 9/8/2014
Matinas BioPharma Approved To Trade On OTCQB Venture Stage Marketplace 9/8/2014
NeoStem, Inc. Letter To Shareholders 9/8/2014
Asterias Biotherapeutics Announces Record Date For Distribution Of BioTime (BTX) Warrants To Holders Of Asterias Series A Common Stock 9/8/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
La Jolla Pharmaceutical Company (LJPC) To Provide Corporate Overview At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Axxess Pharma, Inc. Provides Shareholder Update 9/8/2014
Panther Biotechnology Announces A 6-1 Forward Stock Split To Increase Liquidity Of Their Common Stock And Intent To List On The NYSE Or NASDAQ 9/8/2014
Loxo Oncology (LOXO) Announces Closing Of Initial Public Offering And Partial Exercise Of Over-Allotment Option 9/5/2014
Ablynx (ABLYF) Establishes Sponsored Level I ADR Programme In The United States 9/5/2014
Allergan Inc. (AGN) Provides Update On Written Requests From Pershing Square Regarding Special Meeting Of Stockholders 9/5/2014
InterMune, Inc. (ITMN) Announces Anticipated Fundamental Change For 5.00% Convertible Senior Notes Due 2015 9/5/2014
Depomed, Inc. (DEPO) Announces Pricing Of Upsized $300 Million Convertible Senior Notes Due 2021 9/5/2014
Inovio Pharmaceuticals (INO) To List On NASDAQ 9/4/2014
Clovis Oncology (CLVS) Announces Pricing Of $250 Million Of Convertible Senior Notes 9/4/2014
Perrigo Company (PRGO) Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 9/4/2014
Alere Inc. (ALR) Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock 9/4/2014
ReVance Therapeutics, Inc. (RVNC) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/3/2014
Otonomy, Inc. (OTIC) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/3/2014
BioDelivery Sciences International (BDSI) To Ring The NASDAQ Stock Market Opening Bell 9/3/2014
Horizon Discovery Group Plc: Notice Of Interim Results 9/3/2014
Clovis Oncology (CLVS) To Offer $200 Million Of Convertible Senior Notes 9/3/2014
Depomed, Inc. (DEPO) Announces Offering Of $230 Million Convertible Senior Notes Due 2021 9/3/2014
BioDelivery Sciences International (BDSI) To Ring The NASDAQ Stock Market Opening Bell 9/3/2014
Marinus Pharmaceuticals (MRNS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock 9/2/2014
Agile Therapeutics, Inc. To Ring The NASDAQ Stock Market Closing Bell 9/2/2014
Aurinia (ISA.TO) To Begin Trading On The NASDAQ Global Market 9/2/2014
Cellectis (ALCLS): Genome Engineering & CART Cells: At The Forefront Of Immuno-Oncology 9/2/2014
Nordic Nanovector – Subsequent Offering 9/2/2014
VentiRx Pharmaceuticals, Inc. Provides Corporate And Clinical Update 9/2/2014
Stellar Biotechnologies, Inc. Reports On Unusual Trading Activity 9/2/2014
Daxor Corporation (DXR) Announces Filing Of Form N-CSR For June 30, 2014 9/2/2014
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014
Advanced Cell Technology Announces 1:100 Reverse Stock Split 8/28/2014
Allenex AB: Sales +15% Jan-Jun 2014 8/28/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
NeuroSigma, Inc. Files Registration Statement for Proposed Initial Public Offering 8/27/2014
Sinovac Biotech Ltd. (SVA) Announces Results Of 2014 Annual General Meeting Of Shareholders 8/27/2014
Transcat, Inc. (TRNS) Increases Secured Revolving Credit Facility 8/27/2014
BioDelivery Sciences International (BDSI) To Host Investor And Analyst Event And Webcast Friday, September 5 On BUNAVAIL™ Launch And Pipeline 8/27/2014
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
Wound Management Technologies, Inc. Announces Its 2014 Annual Meeting Of Shareholders 8/26/2014
Marinus Pharmaceuticals (MRNS) To Ring The Opening Bell Of The NASDAQ Stock Market 8/25/2014
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Landauer (LDR) Declares Regular Cash Dividend 8/25/2014
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Ordinary Shares And American Depositary Shares Of CFR Pharmaceuticals 8/25/2014
Asterias Biotherapeutics Announces Investor Briefing Conference Call And Webcast 8/25/2014
BioGenerator Funds Woman-led EDIS Solutions 8/25/2014
Letter To The Ampio Pharmaceuticals, Inc. (AMPE) Shareholders In Regard To The STEP Study And Ampio's Plans For The Ampion™ BLA 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
Pershing Square Submits Requisite Requests From Allergan Inc. (AGN) Shareholders To Call Special Meeting 8/25/2014
Easton Pharmaceuticals (OP: EAPH) Announces Financing Update; Provides Additional Due Diligence Documents To Canadian Based Brokerage Firm Towards Financing 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Lemelson Capital Comments On Large Institutional Selling In Shares Of Ligand Pharmaceuticals Inc. (LGND) Amidst Company's Insolvency And Mounting Going Concern Risk 8/25/2014
NeoGenomics, Inc. (NGNM.OB) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 8/22/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
Cellectar Biosciences  (NVLT) Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option 8/21/2014
Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution 8/21/2014
Henry Schein, Inc. (HSIC) To Present At Two Investor Conferences In September 8/21/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Marina Biotech, Inc. (MRNA) Regains Compliance With Exchange Act Reporting Obligations 8/21/2014
Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc. 8/21/2014
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 8/21/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/20/2014
Lorus Therapeutics Inc. (LRP) Announces Results Of Annual And Special Meeting Of Shareholders 8/20/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Ocular Therapeutix, Inc. (OCUL) Announces Exercise Of Over-Allotment Option 8/20/2014
Adamis Pharmaceuticals (ADMP) Announces Private Placement 8/20/2014
Celladon Corporation Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/19/2014



//-->